314 filings
Page 5 of 16
8-K
azi1svfg 8iw0g
17 May 21
CytoDyn Signs Distribution Agreement with Macleods Pharmaceuticals Ltd. to Pursue EUA and Compassionate Use Access to Leronlimab in India
5:00pm
8-K
hdg125bml1
29 Apr 21
Entry into a Material Definitive Agreement
4:30pm
8-K
86ehmaw1vgl
21 Apr 21
Entry into a Material Definitive Agreement
4:31pm
8-K
692olnk2c
12 Apr 21
CytoDyn Signs Exclusive Supply and Distribution Agreement with Biomm S.A. in Brazil for COVID-19 and All Other Leronlimab Indications
4:30pm
8-K
18r800uumq zjff
8 Apr 21
Entry into a Material Definitive Agreement
8:33am
8-K
8pvwj8wdv
7 Apr 21
Regulation FD Disclosure
4:01pm
8-K
khtq6iet
16 Mar 21
CytoDyn Appoints Christopher Recknor, M.D., as Chief Operating Officer
8:30am
8-K
ycl49
8 Mar 21
Regulation FD Disclosure
5:27pm
8-K
bfe6q770rnoalup0cyjd
2 Mar 21
In the Court of Chancery of the State of Delaware
8:31am
8-K
hqyi5yy gde4fja7o0
29 Jan 21
Entry into a Material Definitive Agreement
8:31am
8-K
jzpiwfhzo4
16 Nov 20
Entry into a Material Definitive Agreement
4:55pm
8-K
kkssjxlao qx5a66vs9c
1 Oct 20
Departure of Directors or Certain Officers
3:09pm
8-K
twygpkgmefu
30 Sep 20
Regulation FD Disclosure
12:30pm
8-K
nx2hogkvqmv q6
18 Aug 20
Departure of Directors or Certain Officers
4:30pm
8-K
cj6x4ikte1c
31 Jul 20
Entry into a Material Definitive Agreement
5:20pm
8-K
mx1ing
24 Jul 20
Entry into a Material Definitive Agreement
4:34pm
8-K
61jpxo3xsc 50
8 Jul 20
Entry into a Material Definitive Agreement
4:30pm
8-K
ti0w9o3szok
19 Jun 20
Departure of Directors or Certain Officers
5:19pm
8-K
why32s fyu
2 Jun 20
Departure of Directors or Certain Officers
5:00pm
8-K/A
u1a2i1s 3o
2 Jun 20
Departure of Directors or Certain Officers
8:00am